Search hospitals > Missouri > Lees Summit
University of Kansas Cancer Center - Lee's Summit
Claim this profileLees Summit, Missouri 64064
Global Leader in Lung Cancer
Global Leader in Breast Cancer
Conducts research for Prostate Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Cancer
188 reported clinical trials
44 medical researchers
Summary
University of Kansas Cancer Center - Lee's Summit is a medical facility located in Lees Summit, Missouri. This center is recognized for care of Lung Cancer, Breast Cancer, Prostate Cancer, Non-Small Cell Lung Cancer, Cancer and other specialties. University of Kansas Cancer Center - Lee's Summit is involved with conducting 188 clinical trials across 507 conditions. There are 44 research doctors associated with this hospital, such as Jun Zhang, Chao H. Huang, Anwaar Saeed, and Gary C. Doolittle.Area of expertise
1Lung Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderStage IV
HER2 negative
ER positive
Top PIs
Jun ZhangHouston Methodist Hospital5 years of reported clinical research
Expert in Lung Cancer
Studies Non-Small Cell Lung Cancer
28 reported clinical trials
43 drugs studied
Chao H. HuangUniversity of Kansas Health System Saint Francis Campus6 years of reported clinical research
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
22 reported clinical trials
35 drugs studied
Anwaar SaeedUniversity of Kansas Cancer Center3 years of reported clinical research
Studies Colorectal Cancer
Studies Liver Cancer
20 reported clinical trials
37 drugs studied
Gary C. DoolittleSalina Regional Health Center2 years of reported clinical research
Studies Melanoma
Studies Lung Cancer
20 reported clinical trials
36 drugs studied
Clinical Trials running at University of Kansas Cancer Center - Lee's Summit
Lung Cancer
Bladder Cancer
Prostate Cancer
Breast Cancer
Skin Cancer
Breast cancer
Bladder Carcinoma
Pancreatic Cancer
Kidney Cancer
Cancer
High-Dose Radiation + Chemotherapy and Immunotherapy
for Non-Small Cell Lung Cancer
This trial tests whether adding a precise form of radiation therapy to the usual treatment improves outcomes for patients with advanced lung cancer that can't be operated on. The goal is to see if this combination helps patients live longer and prevents cancer from worsening. This form of radiation therapy has shown promise in improving survival rates in patients with various stages of lung cancer.
Recruiting2 awards Phase 314 criteria
Proton Craniospinal Radiation
for Cancer in the Brain and Spinal Cord
This phase III trial compares proton craniospinal irradiation (pCSI) to involved-field radiation therapy (IFRT) for the treatment of breast or non-small cell lung cancer that has spread from where it first started to the cerebrospinal fluid filled space that surrounds the brain and spinal cord (leptomeningeal metastasis). Patients with leptomeningeal metastasis (LM) may develop multiple areas of nervous system (neurologic) impairment that can be life-threatening. Radiation therapy (RT) effectively relieves local symptoms due to LM. RT uses high energy radiography (x-rays), particles, or radioactive seeds to kill cancer cells and shrink tumors. IFRT is commonly used to treat symptoms of LM. IFRT is radiation treatment that uses x-rays to treat specific areas of LM and to relieve and/or prevent symptoms. pCSI uses protons that can be directed with more accuracy than x-rays which allows treatment of the entire central nervous system space containing the cerebrospinal fluid (CSF), brain, and spinal cord. The pCSI treatment could delay the worsening of LM. Giving pCSI may be better than IFRT in treating LM in patients with breast or non-small cell lung cancer.
Recruiting2 awards Phase 33 criteria
Chemotherapy + Immunotherapy vs. Immunotherapy
for Advanced Lung Cancer
This phase III trial compares the effect of adding chemotherapy to immunotherapy (pembrolizumab) versus immunotherapy alone in treating patients with stage IIIB-IV lung cancer. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab and chemotherapy may help stabilize lung cancer.
Recruiting2 awards Phase 3
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at University of Kansas Cancer Center - Lee's Summit?
University of Kansas Cancer Center - Lee's Summit is a medical facility located in Lees Summit, Missouri. This center is recognized for care of Lung Cancer, Breast Cancer, Prostate Cancer, Non-Small Cell Lung Cancer, Cancer and other specialties. University of Kansas Cancer Center - Lee's Summit is involved with conducting 188 clinical trials across 507 conditions. There are 44 research doctors associated with this hospital, such as Jun Zhang, Chao H. Huang, Anwaar Saeed, and Gary C. Doolittle.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.